Understanding the Causes and Body Types in Asthma (Tamaka Shwasa) and Comparing the Effects of Two Ayurvedic Herbs Pushkarmula and Somlata in Its Treatment.

The conceptual study of Nidan & Deha Prakriti in relation to Tamaka Shwasa w.s.r. to Bronchial Asthma and its management with Pushkarmula (Inula racemosa Hook. f. ) in comparison to Somlata (Ephedra gerardiana Wall - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088229

Enrollment

Registered

2025-06-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J709- Respiratory conditions due to unspecified external agent

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling the diagnostic criteria. 2. Patients willing to participate in the trial. 3. Patient in the age group between 16 70 years 4. Patients with mild to moderate presentation in symptoms.

Exclusion criteria

Exclusion criteria: Patients not willing for the clinical trial. Patients below 16 years and above 70 years of age. Patients suffering from jaundice , anaemia ,hepatitis ,chronic renal disorders , chronic infectious and Other serious disease Pregnant ladies and lactating mothers. Patients suffering from diseases like other chronic respiratory like status asthmaticus, cardiac, hepatic and hormonal disease Any other condition which the principal investigator thinks may jeopardize the study

Design outcomes

Primary

Measure	Time frame
To compare the effects of Pushkarmula and Somlata in reducing asthma symptoms (Tamaka Shwasa). To observe improvement in breathing problems, such as wheezing, coughing, and shortness of breath. To study how different body types (Deha Prakriti) influence asthma and its treatment. To identify common causes (Nidan) that trigger or worsen asthma in patientsTimepoint: Day 0: Baseline assessment, Prakriti analysis, start treatment. Day 14: First follow-up, symptom check, side effects. Day 28: Second follow-up, reassess symptoms and progress. Day 42: Third follow-up, monitor changes. Day 56: Final evaluation, compare outcomes, end of study.	—

Measure

Time frame

To compare the effects of Pushkarmula and Somlata in reducing asthma symptoms (Tamaka Shwasa). To observe improvement in breathing problems, such as wheezing, coughing, and shortness of breath. To study how different body types (Deha Prakriti) influence asthma and its treatment. To identify common causes (Nidan) that trigger or worsen asthma in patientsTimepoint: Day 0: Baseline assessment, Prakriti analysis, start treatment. Day 14: First follow-up, symptom check, side effects. Day 28: Second follow-up, reassess symptoms and progress. Day 42: Third follow-up, monitor changes. Day 56: Final evaluation, compare outcomes, end of study.

—

Secondary

Measure	Time frame
The secondary outcome of this study includes assessing the long-term sustainability of symptom relief, impact on quality of life, and changes in Prakriti-based response patterns. It also evaluates the safety profile of Pushkarmula and Somlata, reduction in the use of conventional medications, and influence on Nidan (causative factors) in disease progression.Timepoint: The secondary outcome assessment will be conducted at key time points: Baseline (Day 0): Evaluation of quality of life, Prakriti influence, and dependency on conventional medication. Week 4: Mid-study review of symptom sustainability and safety profile. Week 8 (Final Assessment): Analysis of long-term symptom relief, medication reduction, and impact on Nidan factors.	—

Measure

Time frame

The secondary outcome of this study includes assessing the long-term sustainability of symptom relief, impact on quality of life, and changes in Prakriti-based response patterns. It also evaluates the safety profile of Pushkarmula and Somlata, reduction in the use of conventional medications, and influence on Nidan (causative factors) in disease progression.Timepoint: The secondary outcome assessment will be conducted at key time points: Baseline (Day 0): Evaluation of quality of life, Prakriti influence, and dependency on conventional medication. Week 4: Mid-study review of symptom sustainability and safety profile. Week 8 (Final Assessment): Analysis of long-term symptom relief, medication reduction, and impact on Nidan factors.

—

Countries

India

Contacts

Public ContactDr Akhilesh Kumar Srivastava

Rajiv Gandhi Government Post Graduate Ayurvedic College And Hospital

drakhilesh.srivastava@yahoo.com6230118318

Outcome results